BiotechTube
Home/Merakris Therapeutics/Dr. Roger Ilagan
DR

Dr. Roger Ilagan

Chief Scientific Officer

Merakris Therapeutics

Therapeutic Areas

Wound HealingOphthalmology

Merakris Therapeutics Pipeline

DrugIndicationPhase
MTX-001Venous Leg Ulcers (Chronic Wound Healing)Phase 2
Opticyte MatrixOphthalmic Surgical ProceduresCommercial
Dermacyte MatrixAdvanced Wound CareCommercial

Leadership Team at Merakris Therapeutics

TC
T. Christopher Broderick
Director & Chief Executive Officer
WE
Walter E. Daniels
Director
View full Merakris Therapeutics profile